Posts Tagged ‘SZYM’

The Exit: Knowing When to Fold ’em

February 15, 2013 Leave a comment

or: What Goes Up, Must Come Down.

How do you know the right time to exit a position?  Everything you hear is always about initiating the trade or what the next big stock will be, but rarely does anyone talk about what you’re supposed to do once you’re left holding the bag.  Even if the trade generates profits, how do you know when is the best moment to realize your gains and take it off the table?

The simple answer is that you have no way of knowing when that “right” time is.  A lot of people talk about how it’s a “gut feel” or that they “just know”, but that’s all hand-waving exercises at best and self-delusional at worst.  Sure, the more experience you gain, the more often you will have encountered a similar situation and therefore better equipped to anticipate previously made errors.  But knowing when to accept losses or realize gains is a crucial part of playing the stock market and even life itself (I know, we’re getting deep here).

It doesn’t matter who you are or what level of investor you are, you will inevitably make incorrect calls.  Even the big guys make bad calls all the time.  It’s also very, very rare to be right 100% of the time.  So it’s best to accept the fact that you will make mistakes and you will make decisions that seem like a good idea at the time with all the available information.  There are things you can do, however, to offset your losses or protect yourself when things go awry.

First and foremost, don’t hang it up after a tough loss.  Realize that everyone makes a bad call here and there.  Once you accept that fact, things will be a lot easier to deal with when they do unravel.

For downside protection, diversification is an important consideration when developing your portfolio.  The laggards in your portfolio can be helped along with some star performers.  It’s also okay to hit a single and double once in a while and even strike out, as long as you hit the home runs and grand slams once in a while.  Indeed, it’s true in venture capital since it is said that 60% of a venture firm’s returns come from 10% of their capital.  According to the National Venture Capital Association, 20% or less of a firm’s capital generates high returns.  Of course, the type of investing you do in the stock market isn’t nearly as high risk as venture investing, but the concept is the same.  Diversify your portfolio so as to mitigate losses.  Diversification can take on different forms, too, including investing in different sectors, growth stages, or even investment vehicles (that is, perhaps investing in equities, treasuries, bonds, forex, etc.).

Hedging is another strategy to utilize for downside protection.  This can take the form of inverse ETFs, such as ones linked here, or a volatility index, such as the VIX, explained well here, or by using a protective put.  .  Keep in mind leveraged ETFs aren’t built to be held for long periods of time, especially leveraged inverse ETFs.  Their value decays and they are prone to wild swings.  Just use these as tools for hedging your long positions when you’re unsure of market direction, but you still want long exposure.

Additionally, it helps to consider your timeframe for investing.  Consider this diagram linked here from The New York Times.  It illustrates yearly percentage return patterns in the S&P 500 going back to 1920.  The basic premise of the diagram is that your returns on your investment are entirely dependent on what year you both initiate positions and exit positions.  Let’s say you invested in 1980 and took your money out in 1984.  Your return would be around 0-3% per year.  That would have been a pretty crummy return on your investment.  But let’s say you held on to your investment for 20 years.  The return would come out to around 8% per year.  Now that’s not bad.  So in short, timing matters.

If you’ve recently taken a loss and your timeframe is long-term, pay no mind, you’ll make it up.  If you’ve held on to some profitable stocks and you’ve got a short-term timeframe, take some profits off the table.  So always pay attention to what your time frame is and you’ll be able to shrug off losses and take your gains.

SZYM Daily,

SZYM Daily,

I know it might seem like I talk up SZYM a lot here, but aside from my bullishness, I think it’s an educational stock.  I half-expected a pullback from the recent run-up so I’m not too surprised by the dip in trading on Friday, 2/15, as we’re at levels of resistance.  As I mentioned, if your timeframe is short-term, and you’re in under $8, Friday would have been a good time to get out.  An astute trader would have seen the  bullish indicators on 1/31 (20-day moving average, MACD, etc) and initiated a position.  Further, the astute short-term trader would have anticipated a pullback at resistance levels and exited their position on Friday, 2/15.  This would have provided a 10% return, possibly more, of realized gains.

However, as a long-term investor, I would be okay not taking any profits off the table since I would be looking to ride it up past the current price levels.  So always keep your timeframe in mind.

Of course, there is nothing earth shattering, here, but these are important considerations when faced with a big loss or gain.

These concepts can even be applied to life itself.  How do you know when to let go of a long-held personal or professional goal despite all odds seemingly against you?  Simple: You don’t let go.  You diversify your approach in attaining your goal, hedge your risks, and consider your timeframe for what you want to achieve.  If one route proves difficult or doesn’t pan out how you’d like, have plan B, and even plan C ready to go.  As it happens, my motivation for the Pi Shaped Blog is to diversify.

So if you’ve just been hit with a loss, stick with it.  Most importantly: stay hungry, stay foolish.*

*Steve Jobs, Stanford Commencement Speech, 2005

SZYM: Technicals Turning Bullish

February 11, 2013 24 comments

A few weeks ago I mentioned Solazyme to be an interesting play.  Indeed, as of 2/11/13, SZYM is up around 14% since I posted on 1/26/13.  The technicals have since turned slightly bullish and the price has now been hovering at a key level of resistance at $8.50.  Check out the chart below:

SZYM Weekly,

SZYM Weekly,

The green arrows indicate bullish technicals and would have been a great time to enter the stock.  The price price breached the 20-day Moving Average as shown by the top green arrow.  The lower green arrow shows a bullish MACD.

If the bulls can break this key resistance here, we’re heading up to major resistance at around $9.60.  One caveat here is if we cannot breach the $8.50 level, we’ll head back down to the 20-day moving average, around $7.80, which wouldn’t be so bad as I would think some consolidation is in order before a major move up to $9.60.

Keep an eye out for some volatility here, but I’m liking how SZYM is setting up for 2013.

It should be noted that all transactions described on this blog were performed on the Investopedia Stock Simulator and not in the real stock market.  I have no actual positions in any stocks mentioned nor will I be initiating any actual positions in the next 6 months.  Furthermore, the information on this blog should not be considered financial advice.  The main purpose of the blog is to educate its readership, myself included, about concepts and ideas that were previously unknown to me.

Science, People, IP

January 26, 2013 Leave a comment

or What Qualities I Look For in a Company.

After experimenting with various trading styles, it seems as though I am most comfortable as a Growth Investor.  Of course, the type of trader/investor you are is dynamic and can change with every trade you perform.  I’d like to consider myself a Growth Investor, but I also look at technicals and consider a company’s value before I buy, does that make me a Value Investor or maybe even a Technical Trader?  At our core, however, we all have our favorite ways of trading.  And if you don’t right now, yours will develop as you learn more about the market and what types of companies to which you are drawn.  Are you drawn to companies whose share prices have plummeted due to panic-induced overselling, but are still fundamentally good companies?  You may have been drawn to NFLX or RIMM and caught their recent price pops because they still have valid business plans.

For me, I’m drawn to biotech because of my experience in the drug discovery industry.  I really enjoy researching companies in the sector, seeing what therapeutics they have in the pipeline, and trying to predict how their pipeline fit in with the market.  It also helps me better understand the broader pharmaceutical industry, so I can do my actual, real-life job better. I like picking biotechs that I think will be high growth in the medium to long term.  So the title refers specifically to biotech companies, but the concept can be applied to a company in any sector when analyzing a potential investment of a company.

First and foremost, what is their Science?  In other words, what is the fundamental core of the company’s platform?  In the case of NFLX, their “science” is the ability to stream (almost) any TV show or movie at the click of a button.  No more speeding to blockbuster to avoid a late fee, no more scratched DVDs, and soon say “so long” to the days of sitting on your couch to watch a movie.  You now have the ability to stream anywhere you want.  This is the science behind NFLX and it’s seems to be a good business model.  Of course, they are reliant upon obtaining licenses from the industry for their movies, which is the reason why your favorite movie might not be available to stream.

Second, who are the People who run the business?  What have they accomplished so far in their life prior to their position in the company?  If they are young (as is the case with many tech companies), are they high potential individuals who are knowledgeable enough to know how to solve the company’s problems as they scale?  Look at ALNY, for example.  I’m extremely bullish on them for a number of reasons, but their management team looks solid.  There are Harvard MBAs, MIT PhDs, and a number of notable scientists on the Scientific Advisory Board.  Clearly, some pretty prominent people are leading Alnylam and, as such, I would anticipate them to be able to solve many problems they come across.

Third, what kind of Intellectual Property does the company own?  This particular metric is the X-factor for the company and one often overlooked.  Because no other company or entity can use another company’s IP, a company’s IP can help differentiate it from other companies in the sector.

Solazyme (SZYM) is a company that I’ve had my eye on for some time now because, in my opinion, it fits all my criteria for a fundamentally solid company in which I should invest.  Their Science?  SZYM is developing renewable fuel.  Think about that for 5 seconds.  I like big ideas.  I like ideas that will disrupt common thought.  I like ideas that completely and positively change the way things are done.  To me, this is one of those ideas.

O.K., you say, so they have a solid plan.  What kind of people are running the thing?  A PhD from Caltech, a few NYU MBAs, and a whole heck of a lot of combined operating experience.  And that’s just management, I didn’t even get to strategic and scientific advisors.  Needless to say, I think the team is doing a solid job, and will continue to do so. So, do they have any IP? Yeah, just a few patents.

So why aren’t I fully invested?

SZYM Daily Chart,

SZYM Daily Chart,

Technicals, technicals, technicals.  Since SZYM’s IPO, they’ve generally been in a downward sloping pennant.  It’s difficult to justify jumping into the stock with a chart looking the way SZYM does.  It seems as though many are scared off from the insider selling that’s been going on.  Particularly, there’s the curious selling from the CEO himself.  He’s essentially been dumping shares on the market monthly.  Regardless, I don’t mind eating crow for 5 years as the stock price most likely drops to $2.50, but they’re ramping up production and in the next few years, they’ll generate some strong revenue.  You heard it here first.

After starting a new portfolio from scratch this month, I’ve hit the ground running this year.

Courtesy of

2013, Stock Only, From

It’s difficult to believe ACHN has a market capitalization of only $744M when you consider that when Inhibitex was bought by BMS, it was valued at $2.5 billion.  I give a price target of $25.

So as you can see, I try to adhere to my investment thesis of picking high growth biotechs that are based on good science, are managed by a solid team, and own some key assets.  These are just a few of the considerations I look at when I’m analyzing a company.  There are others, but that’ll be for another blog post.

As always: It should be noted that all transactions described on this blog were performed on the Investopedia Stock Simulator and not in the real stock market.  I have no actual positions in any stocks mentioned nor will I be initiating any actual positions in the next 6 months.  Furthermore, the information on this blog should not be considered financial advice.  The main purpose of the blog is to educate its readership, myself included, about concepts and ideas that were previously unknown to me.

Guy Kawasaki

What Shape Are You?

Seeing Both Sides

What Shape Are You?


Some thoughts from a scientist who moved to the business side of biotech

Society & Social Media

Adam Gismondi, Ph.D. // Tufts University

In the Pipeline

What Shape Are You?


What Shape Are You?

This Week In Startups

What Shape Are You?


Recovering scientist turned early stage VC | A biotech optimist fighting gravity

%d bloggers like this: